David Cohen and Sammy Elmariah cover the late-breaking presentations from the last day of NY Valves.
NEW YORK, NY—A systematic program designed to close the diagnosis and treatment gaps for patients with aortic stenosis (AS) ...
NEW YORK, NY—Patients who undergo mitral transcatheter edge-to-edge repair (M-TEER) for symptomatic severe mitral ...
Data from VIRGO and NHANES linked early menarche, age at first birth, and other factors to risk of early-onset acute MI.
M-TEER With PASCAL for Cardiogenic Shock Secondary to Acute Papillary Muscle Rupture Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Primary results of the ENCIRCLE trial led to approval of the M3 device by the US Food and Drug Administration as the first ...
“TAVR with the Sapien 3 platform demonstrated comparable 7-year durability to surgery, supporting its use as a treatment option in lifetime management of low-risk patients with symptomatic severe AS,” ...
While the dataset is incomplete, the death and stroke curves appear to separate at 2 years, notes Philippe Généreux.
Cardiovascular surgery seems to be just as safe in patients with concomitant multiple sclerosis (MS) as in those without the ...
The TCTMD journalists talk about 10-year TAVI data, a FLOW subanalysis, and women's heart centers in Europe. NY Valves ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results